Instead of asking 'why not stack them,' the question becomes 'what specific outcome justifies adding a second compound with incomplete human safety data?' For research exploring maximal metabolic intervention where single-agent tirzepatide has plateaued, the stack may be defensible
It is generally believed that secondary pathological changes caused by diabetes, such as renal dysfunction, often lead to elevated plasma Hcy level, and the impact of diabetes itself on Hcy needs further study (50)
The symptoms that have been most reported to us are pretty consistent with what you would anticipate at a normal dose, but just a little more exaggerated
Minimal add-ins that trigger symptoms
Injection site reactions : Mild and transient
The Pheomelanin Switch Scientists have discovered that glutathione can influence which type of melanin your body produces